Infinity Pharma to stop developing drug for rheumatoid arthritis

January 8, 2015 12:52 PM

15 0

(Reuters) - Infinity Pharma said it would stop testing its lead drug as a treatment for rheumatoid arthritis after it failed the main goal in a mid-stage study.

The company's shares fell 10 percent to $14.75 in premarket trading on Thursday.

Read more

To category page